$8.68
-0.32-3.56%
At close: -
$9.37
0.697.95%
After Hours: Nov 27, 8:34 AM EDT
Comments
Loading...
Actuate Therapeutics (NASDAQ:ACTU) Stock, Earnings Estimates, EPS, And Revenue
Actuate Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 13
EPS
$-0.550
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Actuate Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Actuate Therapeutics (ACTU) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Actuate Therapeutics (ACTU) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Actuate Therapeutics (NASDAQ:ACTU) reporting earnings?
Actuate Therapeutics (ACTU) is scheduled to report earnings on February 21, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Actuate Therapeutics (NASDAQ:ACTU)?
The Actual EPS was $-0.55, which missed the estimate of $0.00.
What were Actuate Therapeutics’s (NASDAQ:ACTU) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.